Calum Fleming

Talking Medicines

Talking Medicines is revolutionising the pharmaceutical industry and the $30Bn it spends on advertising with its innovative data science platform. By harnessing the power of artificial intelligence (AI) and natural language processing (NLP), the platform transforms unstructured social feedback from patients, Health Care Professionals (HCPs) , Key Opinion Leaders (KOL) and Digital Opinion Leaders (DOL) for advertising agencies and their pharmaceutical clients. Using Large Language Models within its advanced AI, clients can answer questions through its Drug-GPT™ of the highly curated and classified healthcare voices to find a single source of truth about lived experience. This allows companies to deliver a greater return on investment for marketing and improves health outcomes for patients. With the data science of Talking Medicines, advertising agencies have access to a scale and depth of insights that was previously impossible, enabling them to make data-driven decisions that drive success. Real time access through SaaS platform PatientMetRx® or configured through data science as a service.